Página Principal Explorar Ajuda
Registe-se Iniciar Sessão
liaoxg
/
cfc
1
1
Fork 0
Ficheiros Problemas 0 Pull Requests 0 Wiki
Ramo: recovered-4
Ramos Etiquetas
cfc
/
web
/
articles
/
alzheimer.html

alzheimer.html 59 KB
Link permanente Histórico Em bruto

12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182838485868788899091929394959697989910010110210310410510610710810911011111211311411511611711811912012112212312412512612712812913013113213313413513613713813914014114214314414514614714814915015115215315415515615715815916016116216316416516616716816917017117217317417517617717817918018118218318418518618718818919019119219319419519619719819920020120220320420520620720820921021121221321421521621721821922022122222322422522622722822923023123223323423523623723823924024124224324424524624724824925025125225325425525625725825926026126226326426526626726826927027127227327427527627727827928028128228328428528628728828929029129229329429529629729829930030130230330430530630730830931031131231331431531631731831932032132232332432532632732832933033133233333433533633733833934034134234334434534634734834935035135235335435535635735835936036136236336436536636736836937037137237337437537637737837938038138238338438538638738838939039139239339439539639739839940040140240340440540640740840941041141241341441541641741841942042142242342442542642742842943043143243343443543643743843944044144244344444544644744844945045145245345445545645745845946046146246346446546646746846947047147247347447547647747847948048148248348448548648748848949049149249349449549649749849950050150250350450550650750850951051151251351451551651751851952052152252352452552652752852953053153253353453553653753853954054154254354454554654754854955055155255355455555655755855956056156256356456556656756856957057157257357457557657757857958058158258358458558658758858959059159259359459559659759859960060160260360460560660760860961061161261361461561661761861962062162262362462562662762862963063163263363463563663763863964064164264364464564664764864965065165265365465565665765865966066166266366466566666766866967067167267367467567667767867968068168268368468568668768868969069169269369469569669769869970070170270370470570670770870971071171271371471571671771871972072172272372472572672772872973073173273373473573673773873974074174274374474574674774874975075175275375475575675775875976076176276376476576676776876977077177277377477577677777877978078178278378478578678778878979079179279379479579679779879980080180280380480580680780880981081181281381481581681781881982082182282382482582682782882983083183283383483583683783883984084184284384484584684784884985085185285385485585685785885986086186286386486586686786886987087187287387487587687787887988088188288388488588688788888989089189289389489589689789889990090190290390490590690790890991091191291391491591691791891992092192292392492592692792892993093193293393493593693793893994094194294394494594694794894995095195295395495595695795895996096196296396496596696796896997097197297397497597697797897998098198298398498598698798898999099199299399499599699799899910001001100210031004100510061007100810091010101110121013101410151016101710181019102010211022102310241025102610271028102910301031103210331034103510361037103810391040104110421043104410451046104710481049105010511052105310541055105610571058105910601061106210631064106510661067106810691070107110721073107410751076107710781079108010811082108310841085108610871088108910901091109210931094109510961097109810991100110111021103110411051106110711081109111011111112111311141115111611171118111911201121112211231124112511261127112811291130113111321133113411351136113711381139114011411142114311441145114611471148114911501151115211531154115511561157115811591160116111621163116411651166116711681169117011711172117311741175117611771178117911801181118211831184118511861187118811891190119111921193119411951196119711981199120012011202120312041205120612071208120912101211121212131214121512161217121812191220122112221223122412251226122712281229123012311232123312341235123612371238123912401241124212431244124512461247124812491250125112521253125412551256125712581259126012611262126312641265126612671268126912701271127212731274127512761277127812791280128112821283128412851286128712881289129012911292129312941295129612971298129913001301130213031304130513061307130813091310131113121313131413151316131713181319132013211322132313241325132613271328132913301331133213331334133513361337133813391340134113421343134413451346134713481349135013511352135313541355135613571358135913601361136213631364136513661367136813691370137113721373137413751376137713781379138013811382138313841385138613871388138913901391139213931394139513961397 
  1. <!DOCTYPE html>
    2. 

  2. <html lang="zh-CN">
    3. 

  3. <head>
    4. 

  4. <meta charset="UTF-8">
    5. 

  5. <meta name="viewport" content="width=device-width, initial-scale=1.0">
    6. 

  6. <meta name="description" content="老年痴呆 — 神经炎症、肠脑轴与主动健康：Aβ斑块在症状出现前15年就开始沉积。APOE4基因、Aβ/Tau蛋白是已知的主要病理因素，近年研究揭示慢性神经炎症与肠脑轴失调在小胶质细胞失控中扮演关键角色。修复肠道屏障、调节菌群可能成为延缓认知衰退的新策略。">
    7. 

  7. <meta name="keywords" content="阿尔茨海默病,神经炎症,肠脑轴,小胶质细胞,Aβ淀粉样斑块,tau蛋白缠结,神经退行性疾病,主动健康,预防医学">
    8. 

  8. <meta property="og:title" content="老年痴呆 - 神经炎症、肠脑轴与主动健康 · 浠艾福">
    9. 

  9. <meta property="og:description" content="Aβ斑块在症状出现前15年就开始沉积。APOE4基因、Aβ/Tau蛋白是已知主要病理因素，近年研究揭示慢性神经炎症与肠脑轴失调在小胶质细胞失控中扮演关键角色。修复肠道屏障、调节菌群可能成为延缓认知衰退的新策略。">
    10. 

  10. <meta property="og:type" content="article">
    11. 

  11. <title>老年痴呆 - 神经炎症、肠脑轴与主动健康 · 浠艾福</title>
    12. 

  12. <style>
    13. 

  13.   :root {
    14. 

  14.     --bg-dark: #1a1a3a;
    15. 

  15.     --bg-card: #FFFFFF;
    16. 

  16.     --bg-alt: #f0f7f0;
    17. 

  17.     --text-primary: #1a1a3a;
    18. 

  18.     --text-secondary: #4a5568;
    19. 

  19.     --text-muted: #718096;
    20. 

  20.     --accent: #27ae60;
    21. 

  21.     --accent-light: #eafaf1;
    22. 

  22.     --blue: #2d7d9a;
    23. 

  23.     --blue-light: #e8f4f8;
    24. 

  24.     --green: #38a169;
    25. 

  25.     --green-light: #f0fff4;
    26. 

  26.     --orange: #dd6b20;
    27. 

  27.     --orange-light: #fffaf0;
    28. 

  28.     --purple: #805ad5;
    29. 

  29.     --purple-light: #faf5ff;
    30. 

  30.     --teal: #319795;
    31. 

  31.     --teal-light: #e6fffa;
    32. 

  32.     --font: system-ui, -apple-system, "PingFang SC", "Microsoft YaHei", "Noto Sans SC", sans-serif;
    33. 

  33.     --max-width: 1080px;
    34. 

  34.     --shadow-card: 0 4px 24px rgba(0,0,0,0.08);
    35. 

  35.     --shadow-hover: 0 8px 40px rgba(0,0,0,0.12);
    36. 

  36.     --radius: 16px;
    37. 

  37.   }
    38. 

  38.   * { margin: 0; padding: 0; box-sizing: border-box; }
    39. 

  39.   html { scroll-behavior: smooth; }
    40. 

  40.   body {
    41. 

  41.     font-family: var(--font);
    42. 

  42.     font-size: 1rem;
    43. 

  43.     line-height: 1.8;
    44. 

  44.     color: var(--text-primary);
    45. 

  45.     background: #fff;
    46. 

  46.     -webkit-font-smoothing: antialiased;
    47. 

  47.   }
    48. 

  48. 

  49.   /* HERO */
    50. 

  50.   .hero {
    51. 

  51.     position: relative;
    52. 

  52.     background: linear-gradient(135deg, #1a1a3a 0%, #2d2d6b 40%, #3a3a8c 100%);
    53. 

  53.     color: white;
    54. 

  54.     padding: 6rem 1.5rem 4rem;
    55. 

  55.     overflow: hidden;
    56. 

  56.     min-height: 60vh;
    57. 

  57.     display: flex;
    58. 

  58.     align-items: center;
    59. 

  59.   }
    60. 

  60.   .hero::before {
    61. 

  61.     content: '';
    62. 

  62.     position: absolute;
    63. 

  63.     inset: 0;
    64. 

  64.     background:
    65. 

  65.       radial-gradient(circle at 20% 30%, rgba(139,92,246,0.15) 0%, transparent 50%),
    66. 

  66.       radial-gradient(circle at 80% 70%, rgba(99,102,241,0.1) 0%, transparent 50%);
    67. 

  67.   }
    68. 

  68.   .hero-particles {
    69. 

  69.     position: absolute;
    70. 

  70.     inset: 0;
    71. 

  71.     overflow: hidden;
    72. 

  72.     pointer-events: none;
    73. 

  73.   }
    74. 

  74.   .particle {
    75. 

  75.     position: absolute;
    76. 

  76.     width: 6px; height: 6px;
    77. 

  77.     background: rgba(255,255,255,0.12);
    78. 

  78.     border-radius: 50%;
    79. 

  79.     animation: float 8s ease-in-out infinite;
    80. 

  80.   }
    81. 

  81.   .particle:nth-child(1) { left: 10%; top: 20%; animation-delay: 0s; width: 4px; height: 4px; }
    82. 

  82.   .particle:nth-child(2) { left: 25%; top: 60%; animation-delay: 1s; width: 8px; height: 8px; opacity: 0.1; }
    83. 

  83.   .particle:nth-child(3) { left: 45%; top: 15%; animation-delay: 2s; width: 5px; height: 5px; }
    84. 

  84.   .particle:nth-child(4) { left: 65%; top: 70%; animation-delay: 0.5s; width: 3px; height: 3px; }
    85. 

  85.   .particle:nth-child(5) { left: 80%; top: 30%; animation-delay: 3s; width: 7px; height: 7px; opacity: 0.08; }
    86. 

  86.   .particle:nth-child(6) { left: 15%; top: 85%; animation-delay: 1.5s; width: 4px; height: 4px; }
    87. 

  87.   .particle:nth-child(7) { left: 55%; top: 45%; animation-delay: 2.5s; width: 9px; height: 9px; opacity: 0.12; }
    88. 

  88.   @keyframes float {
    89. 

  89.     0%, 100% { transform: translateY(0) scale(1); opacity: 0.12; }
    90. 

  90.     50% { transform: translateY(-30px) scale(1.5); opacity: 0.25; }
    91. 

  91.   }
    92. 

  92.   .hero-content {
    93. 

  93.     position: relative;
    94. 

  94.     z-index: 1;
    95. 

  95.     max-width: var(--max-width);
    96. 

  96.     margin: 0 auto;
    97. 

  97.     text-align: center;
    98. 

  98.     width: 100%;
    99. 

  99.   }
    100. 

  100.   .hero-badge {
    101. 

  101.     display: inline-block;
    102. 

  102.     background: rgba(139,92,246,0.2);
    103. 

  103.     color: #a78bfa;
    104. 

  104.     font-size: 0.75rem;
    105. 

  105.     font-weight: 600;
    106. 

  106.     letter-spacing: 0.08em;
    107. 

  107.     padding: 0.35rem 1rem;
    108. 

  108.     border-radius: 999px;
    109. 

  109.     border: 1px solid rgba(139,92,246,0.3);
    110. 

  110.     margin-bottom: 1.5rem;
    111. 

  111.   }
    112. 

  112.   .hero h1 {
    113. 

  113.     font-size: clamp(2rem, 5vw, 3.2rem);
    114. 

  114.     font-weight: 800;
    115. 

  115.     line-height: 1.2;
    116. 

  116.     margin-bottom: 1rem;
    117. 

  117.     background: linear-gradient(135deg, #fff 40%, #c4b5fd 100%);
    118. 

  118.     -webkit-background-clip: text;
    119. 

  119.     -webkit-text-fill-color: transparent;
    120. 

  120.     background-clip: text;
    121. 

  121.   }
    122. 

  122.   .hero p {
    123. 

  123.     font-size: clamp(1rem, 2vw, 1.2rem);
    124. 

  124.     color: rgba(255,255,255,0.8);
    125. 

  125.     max-width: 700px;
    126. 

  126.     margin: 0 auto 2rem;
    127. 

  127.     line-height: 1.7;
    128. 

  128.   }
    129. 

  129.   .hero-stats {
    130. 

  130.     display: flex;
    131. 

  131.     gap: 1.5rem;
    132. 

  132.     justify-content: center;
    133. 

  133.     flex-wrap: wrap;
    134. 

  134.     margin-top: 2rem;
    135. 

  135.   }
    136. 

  136.   .hero-stat {
    137. 

  137.     background: rgba(255,255,255,0.08);
    138. 

  138.     backdrop-filter: blur(8px);
    139. 

  139.     border: 1px solid rgba(255,255,255,0.1);
    140. 

  140.     border-radius: 12px;
    141. 

  141.     padding: 1rem 1.5rem;
    142. 

  142.     text-align: center;
    143. 

  143.     min-width: 130px;
    144. 

  144.   }
    145. 

  145.   .hero-stat .num {
    146. 

  146.     font-size: 1.75rem;
    147. 

  147.     font-weight: 800;
    148. 

  148.     color: #a78bfa;
    149. 

  149.     display: block;
    150. 

  150.   }
    151. 

  151.   .hero-stat .label {
    152. 

  152.     font-size: 0.8rem;
    153. 

  153.     color: rgba(255,255,255,0.6);
    154. 

  154.     margin-top: 0.2rem;
    155. 

  155.   }
    156. 

  156. 

  157.   /* TOC */
    158. 

  158.   .toc {
    159. 

  159.     background: white;
    160. 

  160.     border-bottom: 1px solid #e2e8f0;
    161. 

  161.     position: sticky;
    162. 

  162.     top: 0;
    163. 

  163.     z-index: 100;
    164. 

  164.     box-shadow: 0 1px 4px rgba(0,0,0,0.04);
    165. 

  165.   }
    166. 

  166.   .toc-inner {
    167. 

  167.     max-width: var(--max-width);
    168. 

  168.     margin: 0 auto;
    169. 

  169.     padding: 0.75rem 1.5rem;
    170. 

  170.     display: flex;
    171. 

  171.     gap: 0.25rem;
    172. 

  172.     overflow-x: auto;
    173. 

  173.     -webkit-overflow-scrolling: touch;
    174. 

  174.   }
    175. 

  175.   .toc-inner a {
    176. 

  176.     flex-shrink: 0;
    177. 

  177.     text-decoration: none;
    178. 

  178.     font-size: 0.85rem;
    179. 

  179.     color: var(--text-muted);
    180. 

  180.     padding: 0.4rem 0.8rem;
    181. 

  181.     border-radius: 6px;
    182. 

  182.     transition: all 0.2s;
    183. 

  183.     white-space: nowrap;
    184. 

  184.   }
    185. 

  185.   .toc-inner a:hover { background: var(--bg-alt); color: var(--text-primary); }
    186. 

  186. 

  187.   .container { max-width: var(--max-width); margin: 0 auto; padding: 0 1.5rem; }
    188. 

  188.   section { padding: 4rem 0; }
    189. 

  189.   section.alt { background: var(--bg-alt); }
    190. 

  190. 

  191.   h2 {
    192. 

  192.     font-size: 1.75rem;
    193. 

  193.     font-weight: 700;
    194. 

  194.     margin-bottom: 1.5rem;
    195. 

  195.     line-height: 1.3;
    196. 

  196.   }
    197. 

  197.   h2 .emoji { margin-right: 0.5rem; }
    198. 

  198.   h3 {
    199. 

  199.     font-size: 1.15rem;
    200. 

  200.     font-weight: 600;
    201. 

  201.     margin: 2rem 0 0.75rem;
    202. 

  202.   }
    203. 

  203.   h3:first-child { margin-top: 0; }
    204. 

  204.   p { margin-bottom: 1rem; color: var(--text-secondary); }
    205. 

  205.   .alt p { color: var(--text-secondary); }
    206. 

  206. 

  207.   /* Highlight Box */
    208. 

  208.   .highlight-box {
    209. 

  209.     border-radius: var(--radius);
    210. 

  210.     padding: 1.5rem 2rem;
    211. 

  211.     margin: 1.5rem 0;
    212. 

  212.     border-left: 4px solid;
    213. 

  213.   }
    214. 

  214.   .highlight-box.green { background: var(--green-light); border-color: var(--green); }
    215. 

  215.   .highlight-box.blue { background: var(--blue-light); border-color: var(--blue); }
    216. 

  216.   .highlight-box.orange { background: var(--orange-light); border-color: var(--orange); }
    217. 

  217.   .highlight-box.purple { background: var(--purple-light); border-color: var(--purple); }
    218. 

  218.   .highlight-box.teal { background: var(--teal-light); border-color: var(--teal); }
    219. 

  219.   .highlight-box p:last-child { margin-bottom: 0; }
    220. 

  220. 

  221.   /* Citation Card */
    222. 

  222.   .citation-card {
    223. 

  223.     background: white;
    224. 

  224.     border: 1px solid #e2e8f0;
    225. 

  225.     border-radius: var(--radius);
    226. 

  226.     padding: 1.25rem 1.5rem;
    227. 

  227.     box-shadow: var(--shadow-card);
    228. 

  228.     transition: box-shadow 0.2s;
    229. 

  229.     margin-bottom: 1rem;
    230. 

  230.   }
    231. 

  231.   .citation-card:hover { box-shadow: var(--shadow-hover); }
    232. 

  232.   .citation-card .source {
    233. 

  233.     font-size: 0.75rem;
    234. 

  234.     color: var(--blue);
    235. 

  235.     font-weight: 600;
    236. 

  236.     text-transform: uppercase;
    237. 

  237.     letter-spacing: 0.05em;
    238. 

  238.   }
    239. 

  239.   .citation-card .title { font-weight: 600; font-size: 0.95rem; margin: 0.3rem 0 0.4rem; line-height: 1.4; }
    240. 

  240.   .citation-card .findings { font-size: 0.85rem; color: var(--text-muted); line-height: 1.6; }
    241. 

  241.   .citation-card .link {
    242. 

  242.     display: inline-block; margin-top: 0.5rem; font-size: 0.8rem;
    243. 

  243.     color: var(--blue); text-decoration: none;
    244. 

  244.   }
    245. 

  245.   .citation-card .link:hover { text-decoration: underline; }
    246. 

  246. 

  247.   /* Data Card */
    248. 

  248.   .data-card {
    249. 

  249.     background: white;
    250. 

  250.     border-radius: var(--radius);
    251. 

  251.     padding: 2rem;
    252. 

  252.     text-align: center;
    253. 

  253.     box-shadow: var(--shadow-card);
    254. 

  254.   }
    255. 

  255.   .data-card .big-number {
    256. 

  256.     font-size: 3rem; font-weight: 800; line-height: 1;
    257. 

  257.   }
    258. 

  258.   .data-card .big-number.green { color: var(--green); }
    259. 

  259.   .data-card .big-number.blue { color: var(--blue); }
    260. 

  260.   .data-card .big-number.orange { color: var(--orange); }
    261. 

  261.   .data-card .unit { font-size: 1rem; color: var(--text-muted); font-weight: 400; }
    262. 

  262.   .data-card .desc { font-size: 0.9rem; color: var(--text-secondary); margin-top: 0.5rem; }
    263. 

  263.   .data-grid {
    264. 

  264.     display: grid;
    265. 

  265.     grid-template-columns: repeat(auto-fit, minmax(220px, 1fr));
    266. 

  266.     gap: 1.5rem;
    267. 

  267.     margin: 1.5rem 0;
    268. 

  268.   }
    269. 

  269. 

  270.   /* Two Col Grid */
    271. 

  271.   .two-col-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; }
    272. 

  272.   .two-col-grid-3 { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1rem; }
    273. 

  273. 

  274.   /* Tip Card */
    275. 

  275.   .tip-card {
    276. 

  276.     background: white;
    277. 

  277.     border-radius: var(--radius);
    278. 

  278.     padding: 1.5rem;
    279. 

  279.     box-shadow: var(--shadow-card);
    280. 

  280.     border-top: 3px solid;
    281. 

  281.   }
    282. 

  282.   .tip-card.green { border-color: var(--green); }
    283. 

  283.   .tip-card.blue { border-color: var(--blue); }
    284. 

  284.   .tip-card.orange { border-color: var(--orange); }
    285. 

  285.   .tip-card.purple { border-color: var(--purple); }
    286. 

  286.   .tip-card .tip-icon { font-size: 1.75rem; margin-bottom: 0.5rem; }
    287. 

  287.   .tip-card h4 { font-size: 1rem; font-weight: 600; margin-bottom: 0.4rem; }
    288. 

  288.   .tip-card p { font-size: 0.85rem; color: var(--text-muted); margin-bottom: 0; }
    289. 

  289.   .tip-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 1rem; }
    290. 

  290. 

  291.   /* Infographic */
    292. 

  292.   .infographic {
    293. 

  293.     display: grid;
    294. 

  294.     grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));
    295. 

  295.     gap: 1rem;
    296. 

  296.     margin: 1.5rem 0;
    297. 

  297.   }
    298. 

  298.   .info-item {
    299. 

  299.     text-align: center;
    300. 

  300.     padding: 1.5rem 1rem;
    301. 

  301.     background: white;
    302. 

  302.     border-radius: var(--radius);
    303. 

  303.     border: 1px solid #e2e8f0;
    304. 

  304.   }
    305. 

  305.   .info-item .icon { font-size: 2.5rem; margin-bottom: 0.5rem; }
    306. 

  306.   .info-item h4 { font-size: 0.9rem; font-weight: 600; margin-bottom: 0.3rem; }
    307. 

  307.   .info-item p { font-size: 0.8rem; color: var(--text-muted); margin: 0; }
    308. 

  308. 

  309.   /* Compare Table */
    310. 

  310.   .compare-table {
    311. 

  311.     width: 100%;
    312. 

  312.     border-collapse: collapse;
    313. 

  313.     margin: 1.5rem 0;
    314. 

  314.     font-size: 0.9rem;
    315. 

  315.     background: white;
    316. 

  316.     border-radius: var(--radius);
    317. 

  317.     overflow: hidden;
    318. 

  318.     box-shadow: var(--shadow-card);
    319. 

  319.   }
    320. 

  320.   .compare-table th {
    321. 

  321.     background: var(--bg-dark);
    322. 

  322.     color: white;
    323. 

  323.     padding: 0.75rem 1rem;
    324. 

  324.     text-align: left;
    325. 

  325.     font-weight: 600;
    326. 

  326.   }
    327. 

  327.   .compare-table td { padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; }
    328. 

  328.   .compare-table tr:last-child td { border-bottom: none; }
    329. 

  329.   .compare-table .highlight-cell { background: var(--green-light); font-weight: 600; }
    330. 

  330. 

  331.   /* Mechanism Diagram */
    332. 

  332.   .mechanism-diagram {
    333. 

  333.     margin: 2rem 0;
    334. 

  334.     text-align: center;
    335. 

  335.   }
    336. 

  336.   .mechanism-diagram img {
    337. 

  337.     max-width: 100%;
    338. 

  338.     border-radius: var(--radius);
    339. 

  339.     box-shadow: var(--shadow-card);
    340. 

  340.     border: 1px solid #e2e8f0;
    341. 

  341.   }
    342. 

  342.   .mechanism-diagram .diagram-caption {
    343. 

  343.     font-size: 0.8rem;
    344. 

  344.     color: var(--text-muted);
    345. 

  345.     margin-top: 0.75rem;
    346. 

  346.     line-height: 1.6;
    347. 

  347.     text-align: left;
    348. 

  348.     background: var(--bg-alt);
    349. 

  349.     border-radius: 8px;
    350. 

  350.     padding: 0.75rem 1rem;
    351. 

  351.   }
    352. 

  352.   .mechanism-diagram .diagram-caption strong { color: var(--accent); }
    353. 

  353. 

  354.   /* Screenshot with annotation */
    355. 

  355.   .screenshot-block {
    356. 

  356.     margin: 1.5rem 0;
    357. 

  357.   }
    358. 

  358.   .screenshot-block img {
    359. 

  359.     width: 100%;
    360. 

  360.     max-height: 480px;
    361. 

  361.     object-fit: cover;
    362. 

  362.     object-position: top;
    363. 

  363.     border-radius: var(--radius);
    364. 

  364.     border: 1px solid #e2e8f0;
    365. 

  365.     box-shadow: var(--shadow-card);
    366. 

  366.   }
    367. 

  367.   .screenshot-block .screenshot-note {
    368. 

  368.     font-size: 0.78rem;
    369. 

  369.     color: var(--text-muted);
    370. 

  370.     margin-top: 0.4rem;
    371. 

  371.     line-height: 1.6;
    372. 

  372.   }
    373. 

  373.   .screenshot-block .screenshot-note a { color: var(--blue); }
    374. 

  374. 

  375.   /* Footer */
    376. 

  376.   .site-footer {
    377. 

  377.     background: var(--bg-dark);
    378. 

  378.     color: #fff;
    379. 

  379.     padding: 3rem 0 0;
    380. 

  380.   }
    381. 

  381.   .footer-inner {
    382. 

  382.     display: flex;
    383. 

  383.     justify-content: space-between;
    384. 

  384.     gap: 3rem;
    385. 

  385.     padding-bottom: 2rem;
    386. 

  386.     border-bottom: 1px solid rgba(255,255,255,.1);
    387. 

  387.     flex-wrap: wrap;
    388. 

  388.   }
    389. 

  389.   .footer-brand .logo-text {
    390. 

  390.     color: #fff;
    391. 

  391.     font-size: 1.25rem;
    392. 

  392.     font-weight: 700;
    393. 

  393.   }
    394. 

  394.   .footer-brand .logo-tag {
    395. 

  395.     color: var(--accent);
    396. 

  396.     font-weight: 600;
    397. 

  397.   }
    398. 

  398.   .footer-brand p {
    399. 

  399.     color: rgba(255,255,255,.6);
    400. 

  400.     font-size: 0.85rem;
    401. 

  401.     margin-top: 0.5rem;
    402. 

  402.     max-width: 300px;
    403. 

  403.     line-height: 1.7;
    404. 

  404.   }
    405. 

  405.   .footer-links {
    406. 

  406.     display: flex;
    407. 

  407.     gap: 3rem;
    408. 

  408.     flex-wrap: wrap;
    409. 

  409.   }
    410. 

  410.   .footer-col h4 {
    411. 

  411.     font-size: 0.75rem;
    412. 

  412.     font-weight: 600;
    413. 

  413.     text-transform: uppercase;
    414. 

  414.     letter-spacing: .06em;
    415. 

  415.     color: rgba(255,255,255,.5);
    416. 

  416.     margin-bottom: 1rem;
    417. 

  417.   }
    418. 

  418.   .footer-col ul { list-style: none; }
    419. 

  419.   .footer-col ul li { margin-bottom: 0.5rem; }
    420. 

  420.   .footer-col ul li a {
    421. 

  421.     font-size: 0.85rem;
    422. 

  422.     color: rgba(255,255,255,.7);
    423. 

  423.     transition: color 0.2s;
    424. 

  424.     text-decoration: none;
    425. 

  425.   }
    426. 

  426.   .footer-col ul li a:hover { color: var(--accent); }
    427. 

  427.   .footer-contact li {
    428. 

  428.     font-size: 0.85rem;
    429. 

  429.     color: rgba(255,255,255,.6);
    430. 

  430.     line-height: 1.8;
    431. 

  431.   }
    432. 

  432.   .footer-contact li a { color: rgba(255,255,255,.7); }
    433. 

  433.   .footer-bottom {
    434. 

  434.     text-align: center;
    435. 

  435.     padding: 1.5rem 0;
    436. 

  436.   }
    437. 

  437.   .footer-bottom p {
    438. 

  438.     font-size: 0.75rem;
    439. 

  439.     color: rgba(255,255,255,.4);
    440. 

  440.   }
    441. 

  441.   .footer-logo-img {
    442. 

  442.     display: block;
    443. 

  443.     flex-shrink: 0;
    444. 

  444.     border-radius: 10px;
    445. 

  445.     margin-bottom: 0.5rem;
    446. 

  446.     object-fit: contain;
    447. 

  447.   }
    448. 

  448.   .footer-legal {
    449. 

  449.     margin-top: 0.3rem;
    450. 

  450.     font-size: 0.75rem;
    451. 

  451.     color: rgba(255,255,255,.4);
    452. 

  452.     display: flex;
    453. 

  453.     gap: 1rem;
    454. 

  454.     justify-content: center;
    455. 

  455.     flex-wrap: wrap;
    456. 

  456.   }
    457. 

  457.   .footer-legal a {
    458. 

  458.     color: rgba(255,255,255,.4);
    459. 

  459.     text-decoration: underline;
    460. 

  460.   }
    461. 

  461.   .footer-legal a:hover { color: var(--accent); }
    462. 

  462. 

  463.   /* Ref link icon */
    464. 

  464.   .ref-link-icon {
    465. 

  465.     display: inline-flex;
    466. 

  466.     align-items: center;
    467. 

  467.     gap: 0.3rem;
    468. 

  468.     font-size: 0.8rem;
    469. 

  469.     color: var(--blue);
    470. 

  470.     text-decoration: none;
    471. 

  471.     margin-right: 1rem;
    472. 

  472.   }
    473. 

  473.   .ref-link-icon:hover { text-decoration: underline; }
    474. 

  474. 

  475.   /* Authority badge — 引用权威性标签 */
    476. 

  476.   .authority-badge {
    477. 

  477.     display: inline-flex;
    478. 

  478.     align-items: center;
    479. 

  479.     gap: 0.35rem;
    480. 

  480.     font-size: 0.75rem;
    481. 

  481.     padding: 0.2rem 0.6rem;
    482. 

  482.     border-radius: 999px;
    483. 

  483.     background: #e8f5e9;
    484. 

  484.     color: #2e7d32;
    485. 

  485.     border: 1px solid #a5d6a7;
    486. 

  486.     font-weight: 500;
    487. 

  487.     white-space: nowrap;
    488. 

  488.   }
    489. 

  489.   .authority-badge.high { background: #e3f2fd; color: #1565c0; border-color: #90caf9; }
    490. 

  490.   .authority-badge.medium { background: #fff3e0; color: #e65100; border-color: #ffcc80; }
    491. 

  491.   .authority-badge.review { background: #f3e5f5; color: #7b1fa2; border-color: #ce93d8; }
    492. 

  492.   .authority-badge.rct { background: #e8f5e9; color: #2e7d32; border-color: #a5d6a7; }
    493. 

  493.   .authority-badge.animal { background: #fce4ec; color: #c62828; border-color: #ef9a9a; }
    494. 

  494.   .authority-badge.concept { background: #fff8e1; color: #f57f17; border-color: #ffe082; }
    495. 

  495. 

  496.   /* Evidence screenshot thumbnail */
    497. 

  497.   .evidence-thumb {
    498. 

  498.     display: inline-block;
    499. 

  499.     margin: 0.5rem 0 0.3rem;
    500. 

  500.     border-radius: 8px;
    501. 

  501.     overflow: hidden;
    502. 

  502.     max-width: 100%;
    503. 

  503.     border: 1px solid #e2e8f0;
    504. 

  504.     box-shadow: 0 2px 8px rgba(0,0,0,0.06);
    505. 

  505.     transition: box-shadow 0.2s;
    506. 

  506.     cursor: zoom-in;
    507. 

  507.   }
    508. 

  508.   .evidence-thumb:hover { box-shadow: 0 4px 16px rgba(0,0,0,0.12); }
    509. 

  509.   .evidence-thumb img { display: block; max-width: 100%; height: auto; max-height: 200px; }
    510. 

  510.   .evidence-thumb-label {
    511. 

  511.     display: block;
    512. 

  512.     font-size: 0.7rem;
    513. 

  513.     color: #9ca3af;
    514. 

  514.     text-align: center;
    515. 

  515.     padding: 0.2rem;
    516. 

  516.     background: #f9fafb;
    517. 

  517.     border-top: 1px solid #f3f4f6;
    518. 

  518.   }
    519. 

  519. 

  520.   /* 英文→中文翻译 */
    521. 

  521.   .translation {
    522. 

  522.     display: block;
    523. 

  523.     font-size: 0.82rem;
    524. 

  524.     color: var(--blue);
    525. 

  525.     margin-top: 0.2rem;
    526. 

  526.     padding: 0.3rem 0.5rem;
    527. 

  527.     background: #f0f7ff;
    528. 

  528.     border-radius: 4px;
    529. 

  529.     border-left: 3px solid var(--blue);
    530. 

  530.   }
    531. 

  531.   .translation::before {
    532. 

  532.     content: "📖 中文翻译：";
    533. 

  533.     font-weight: 600;
    534. 

  534.     margin-right: 0.3rem;
    535. 

  535.   }
    536. 

  536. 

  537.   /* Citation card enhancement */
    538. 

  538.   .citation-card {
    539. 

  539.     position: relative;
    540. 

  540.   }
    541. 

  541.   .citation-card .authority-row {
    542. 

  542.     display: flex;
    543. 

  543.     flex-wrap: wrap;
    544. 

  544.     align-items: center;
    545. 

  545.     gap: 0.5rem;
    546. 

  546.     margin: 0.5rem 0 0.3rem;
    547. 

  547.   }
    548. 

  548. 

  549.   /* Ref list */
    550. 

  550.   .ref-list {
    551. 

  551.     font-size: 0.85rem;
    552. 

  552.     line-height: 2;
    553. 

  553.     color: var(--text-muted);
    554. 

  554.   }
    555. 

  555.   .ref-list a { color: var(--blue); text-decoration: none; }
    556. 

  556.   .ref-list a:hover { text-decoration: underline; }
    557. 

  557.   .ref-list li { margin-bottom: 0.3rem; }
    558. 

  558. 

  559.   /* Inline annotated evidence screenshot */
    560. 

  560.   .evidence-inline {
    561. 

  561.     margin: 1.5rem 0;
    562. 

  562.     padding: 1rem;
    563. 

  563.     background: #f8fafc;
    564. 

  564.     border: 1px solid #e2e8f0;
    565. 

  565.     border-radius: var(--radius);
    566. 

  566.     box-shadow: var(--shadow-card);
    567. 

  567.   }
    568. 

  568.   .evidence-inline .evidence-title {
    569. 

  569.     font-size: 0.9rem;
    570. 

  570.     font-weight: 600;
    571. 

  571.     color: var(--text-primary);
    572. 

  572.     margin-bottom: 0.6rem;
    573. 

  573.     display: flex;
    574. 

  574.     align-items: center;
    575. 

  575.     gap: 0.4rem;
    576. 

  576.   }
    577. 

  577.   .evidence-inline .evidence-image-wrap {
    578. 

  578.     position: relative;
    579. 

  579.     display: inline-block;
    580. 

  580.     max-width: 100%;
    581. 

  581.     border-radius: 8px;
    582. 

  582.     overflow: hidden;
    583. 

  583.     border: 1px solid #e2e8f0;
    584. 

  584.   }
    585. 

  585.   .evidence-inline .evidence-image-wrap img {
    586. 

  586.     display: block;
    587. 

  587.     max-width: 100%;
    588. 

  588.     height: auto;
    589. 

  589.     max-height: 220px;
    590. 

  590.   }
    591. 

  591.   .evidence-inline .evidence-highlight {
    592. 

  592.     position: absolute;
    593. 

  593.     top: 18%;
    594. 

  594.     left: 4%;
    595. 

  595.     width: 92%;
    596. 

  596.     height: 28%;
    597. 

  597.     border: 3px dashed #e53e3e;
    598. 

  598.     background: rgba(229, 62, 62, 0.06);
    599. 

  599.     border-radius: 6px;
    600. 

  600.     pointer-events: none;
    601. 

  601.   }
    602. 

  602.   .evidence-inline .evidence-highlight::after {
    603. 

  603.     content: "🔍 关键发现";
    604. 

  604.     position: absolute;
    605. 

  605.     top: -22px;
    606. 

  606.     left: 0;
    607. 

  607.     background: #e53e3e;
    608. 

  608.     color: white;
    609. 

  609.     font-size: 0.7rem;
    610. 

  610.     padding: 0.15rem 0.5rem;
    611. 

  611.     border-radius: 4px;
    612. 

  612.     font-weight: 600;
    613. 

  613.   }
    614. 

  614.   .evidence-inline .evidence-caption {
    615. 

  615.     margin-top: 0.75rem;
    616. 

  616.     font-size: 0.85rem;
    617. 

  617.     color: var(--text-secondary);
    618. 

  618.     line-height: 1.6;
    619. 

  619.   }
    620. 

  620.   .evidence-inline .evidence-translation {
    621. 

  621.     margin-top: 0.5rem;
    622. 

  622.     padding: 0.5rem 0.7rem;
    623. 

  623.     background: #f0f7ff;
    624. 

  624.     border-left: 3px solid var(--blue);
    625. 

  625.     border-radius: 0 6px 6px 0;
    626. 

  626.     font-size: 0.82rem;
    627. 

  627.     color: var(--blue);
    628. 

  628.   }
    629. 

  629.   .evidence-inline .evidence-meta {
    630. 

  630.     margin-top: 0.6rem;
    631. 

  631.     font-size: 0.8rem;
    632. 

  632.     color: var(--text-muted);
    633. 

  633.   }
    634. 

  634.   .evidence-inline .evidence-meta a {
    635. 

  635.     color: var(--blue);
    636. 

  636.     text-decoration: none;
    637. 

  637.   }
    638. 

  638.   .evidence-inline .evidence-meta a:hover { text-decoration: underline; }
    639. 

  639. 

  640.   /* Warning box */
    641. 

  641.   .warning { background: #fff8e1; border-left: 4px solid #f39c12; padding: 0.8rem 1rem; border-radius: 0 6px 6px 0; margin: 1rem 0; font-size: 0.9rem; }
    642. 

  642. 

  643.   /* Responsive */
    644. 

  644.   @media (max-width: 640px) {
    645. 

  645.     .hero { padding: 4rem 1rem 3rem; min-height: auto; }
    646. 

  646.     .hero-stats { gap: 0.75rem; }
    647. 

  647.     .hero-stat { min-width: 100px; padding: 0.75rem 1rem; }
    648. 

  648.     .hero-stat .num { font-size: 1.3rem; }
    649. 

  649.     .data-grid { grid-template-columns: 1fr; }
    650. 

  650.     .two-col-grid { grid-template-columns: 1fr; }
    651. 

  651.     .two-col-grid-3 { grid-template-columns: 1fr; }
    652. 

  652.     .tip-grid { grid-template-columns: 1fr; }
    653. 

  653.     section { padding: 2.5rem 0; }
    654. 

  654.     h2 { font-size: 1.4rem; }
    655. 

  655.     .highlight-box { padding: 1.25rem; }
    656. 

  656.     .compare-table { font-size: 0.8rem; }
    657. 

  657.     .compare-table th, .compare-table td { padding: 0.5rem 0.75rem; }
    658. 

  658.   }
    659. 

  659. </style>
    660. 

  660. </head>
    661. 

  661. <body>
    662. 

  662. 

  663. <!-- ===== HERO ===== -->
    664. 

  664. <header class="hero">
    665. 

  665.   <div class="hero-particles">
    666. 

  666.     <div class="particle"></div><div class="particle"></div><div class="particle"></div>
    667. 

  667.     <div class="particle"></div><div class="particle"></div><div class="particle"></div>
    668. 

  668.     <div class="particle"></div>
    669. 

  669.   </div>
    670. 

  670.   <div class="hero-content">
    671. 

  671.     <div class="hero-badge">🧠 科学循证 · 2024-2026最新研究</div>
    672. 

  672.     <h1>老年痴呆 - 神经炎症、肠脑轴与主动健康</h1>
    673. 

  673.     <p>Aβ斑块在症状出现前15年就开始沉积。APOE4基因、Aβ/Tau蛋白是目前公认的主要病理因素，但近年研究揭示慢性神经炎症与肠脑轴失调在小胶质细胞失控中扮演关键角色，可能是延缓认知衰退的新干预靶点。</p>
    674. 

  674.     <div class="hero-stats">
    675. 

  675.       <div class="hero-stat">
    676. 

  676.         <span class="num">1.7亿</span>
    677. 

  677.         <span class="label">全球阿尔茨海默病患者</span>
    678. 

  678.       </div>
    679. 

  679.       <div class="hero-stat">
    680. 

  680.         <span class="num">65%</span>
    681. 

  681.         <span class="label">神经炎症相关发病机制</span>
    682. 

  682.       </div>
    683. 

  683.       <div class="hero-stat">
    684. 

  684.         <span class="num">15年</span>
    685. 

  685.         <span class="label">症状出现前病理积累</span>
    686. 

  686.       </div>
    687. 

  687.       <div class="hero-stat">
    688. 

  688.         <span class="num">3-4倍</span>
    689. 

  689.         <span class="label">TREM2突变风险增加</span>
    690. 

  690.       </div>
    691. 

  691.     </div>
    692. 

  692.   </div>
    693. 

  693. </header>
    694. 

  694. 

  695. <!-- ===== TOC ===== -->
    696. 

  696. <nav class="toc">
    697. 

  697.   <div class="toc-inner">
    698. 

  698.     <a href="#symptoms">症</a>
    699. 

  699.     <a href="#causes">因</a>
    700. 

  700.     <a href="#step1">STEP 01</a>
    701. 

  701.     <a href="#step2">STEP 02</a>
    702. 

  702.     <a href="#step3">STEP 03</a>
    703. 

  703.     <a href="#step4">STEP 04</a>
    704. 

  704.     <a href="#step5">STEP 05</a>
    705. 

  705.     <a href="#treatment">💊</a>
    706. 

  706.     <a href="#references">参考文献</a>
    707. 

  707.   </div>
    708. 

  708. </nav>
    709. 

  709. 

  710. <!-- ===== SECTION: SYMPTOMS ===== -->
    711. 

  711. <section id="symptoms">
    712. 

  712.   <div class="container">
    713. 

  713.     <h2>🧠 不要等发现症状才开始重视</h2>
    714. 

  714.     
    715. 

  715.     <p>当记忆力下降到影响日常生活的程度时，大脑已经有10-20年的病理积累了。Aβ淀粉样斑块在症状出现前15-20年就开始沉积，tau蛋白缠结在确诊前10年就已蔓延。</p>
    716. 

  716.     
    717. 

  717.     <p><strong>典型认知症状（病理已广泛的标志）：</strong></p>
    718. 

  718.     <ul>
    719. 

  719.       <li>近记忆障碍：无法新近学习的信息保持在记忆中</li>
    720. 

  720.       <li>失语：语言表达或理解能力下降</li>
    721. 

  721.       <li>失用：无法计划或执行日常动作</li>
    722. 

  722.       <li>失认：无法识别熟悉的物品或面孔</li>
    723. 

  723.     </ul>
    724. 

  724.     
    725. 

  725.     <div class="highlight-box blue">
    726. 

  726.       <p><strong>正常老化vs痴呆：</strong>正常老化偶尔忘事但能回忆，痴呆是越来越记不住且无法通过提醒回忆。</p>
    727. 

  727.     </div>
    728. 

  728.     
    729. 

  729.     <div class="warning">
    730. 

  730.       <b>⚠️ 早期识别：</b>一旦出现上述症状，请及时进行MoCA认知评估和神经影像学检查，以排除或确诊阿尔茨海默病。
    731. 

  731.     </div>
    732. 

  732.   </div>
    733. 

  733. </section>
    734. 

  734. 

  735. <!-- ===== SECTION: CAUSES ===== -->
    736. 

  736. <section id="causes" class="alt">
    737. 

  737.   <div class="container">
    738. 

  738.     <h2>🧬 阿尔茨海默病：Aβ/Tau之外，慢性神经炎症的角色</h2>
    739. 

  739.     
    740. 

  740.     <div class="highlight-box purple">
    741. 

  741.       <p><strong>核心论点：</strong>APOE4基因、Aβ/Tau蛋白是AD公认的主要病理因素。近年研究揭示肠道菌群失调通过肠脑轴驱动慢性神经炎症——小胶质细胞从保护者变成破坏者，可能是延缓认知衰退的新干预靶点。</p>
    742. 

  742.     </div>
    743. 

  743.     
    744. 

  744.     <h3>1. Aβ-Tau蛋白之外：炎症才是核心</h3>
    745. 

  745.     
    746. 

  746.     <p>Aβ淀粉样斑块和tau蛋白缠结是阿尔茨海默病（AD）的病理标志，但针对Aβ的药物（如Aducanumab、Lecanemab）临床获益有限。越来越多的证据支持：神经炎症（神经胶质细胞过度激活）是比Aβ/Tau更核心的损伤机制。</p>
    747. 

  747.     
    748. 

  748.     <div class="two-col-grid">
    749. 

  749.       <div class="citation-card" style="border-left:4px solid #805ad5;">
    750. 

  750.         <div class="source">🧬 小胶质细胞的"双面角色"</div>
    751. 

  751.         <div class="findings">
    752. 

  752.           <strong>保护状态（A1表型）：</strong>清除Aβ碎片、修剪不必要的突触（神经发育期正常，AD中失调）<br><br>
    753. 

  753.           <strong>破坏状态（持续激活）：</strong>分泌IL-1β/IL-6/TNF-α/补体→杀死神经元、促进tau磷酸化→突触丢失<br><br>
    754. 

  754.           <strong>TREM2基因突变：</strong>小胶质细胞吞噬能力↓→Aβ清除↓→AD风险↑3-4倍<br><br>
    755. 

  755.           <strong>靶向小胶质细胞抗炎治疗：</strong>成为新的研究热点
    756. 

  756.         </div>
    757. 

  757.       </div>
    758. 

  758.       <div class="citation-card" style="border-left:4px solid #dd6b20;">
    759. 

  759.         <div class="source">⚠️ 临床证据</div>
    760. 

  760.         <div class="findings">
    761. 

  761.           Lecanemab（抗Aβ单克隆抗体）临床获益有限，ARIA风险高<br>
    762. 

  762.           针对神经炎症的药物（如托珠单抗、司库尼布）正在进行临床试验<br>
    763. 

  763.           小胶质细胞状态与AD进展相关性强于Aβ/Tau负荷
    764. 

  764.         </div>
    765. 

  765.       </div>
    766. 

  766.     </div>
    767. 

  767.     
    768. 

  768.     <h3>2. 肠脑轴（Gut-Brain Axis）——肠道炎症→神经炎症</h3>
    769. 

  769.     
    770. 

  770.     <p>肠道与大脑通过神经、免疫、代谢三条途径双向连接。肠道菌群失调→肠漏→LPS进入血液→系统性炎症→血脑屏障通透性↑→大脑小胶质细胞激活。</p>
    771. 

  771.     
    772. 

  772.     <div class="mechanism-diagram">
    773. 

  773.       <svg viewBox="0 0 860 540" xmlns="http://www.w3.org/2000/svg" style="max-width:100%;border-radius:var(--radius);box-shadow:var(--shadow-card);border:1px solid #e2e8f0;background:#fff;">
    774. 

  774.         <!-- Gut (left side) -->
    775. 

  775.         <rect x="30" y="40" width="180" height="200" rx="12" fill="#f0fdf4" stroke="#22c55e" stroke-width="2"/>
    776. 

  776.         <text x="120" y="80" text-anchor="middle" font-size="14" font-weight="700" fill="#166534">肠道 (Gut)</text>
    777. 

  777.         <rect x="50" y="100" width="140" height="40" rx="6" fill="#dcfce7" stroke="#86efac" stroke-width="1"/>
    778. 

  778.         <text x="120" y="125" text-anchor="middle" font-size="11" fill="#15803d">菌群失调 Dysbiosis</text>
    779. 

  779.         <rect x="50" y="150" width="140" height="40" rx="6" fill="#fef2f2" stroke="#fca5a5" stroke-width="1"/>
    780. 

  780.         <text x="120" y="175" text-anchor="middle" font-size="11" fill="#b91c1c">肠漏 Leaky Gut</text>
    781. 

  781.         <text x="120" y="220" text-anchor="middle" font-size="11" fill="#64748b">产丁酸菌↓</text>
    782. 

  782.         <text x="120" y="238" text-anchor="middle" font-size="11" fill="#64748b">促炎菌↑</text>
    783. 

  783. 

  784.         <!-- Gut Microbes icons -->
    785. 

  785.         <circle cx="80" y="260" r="6" fill="#ef4444" opacity="0.6"/>
    786. 

  786.         <circle cx="100" y="270" r="4" fill="#ef4444" opacity="0.5"/>
    787. 

  787.         <circle cx="120" y="258" r="5" fill="#ef4444" opacity="0.7"/>
    788. 

  788.         <circle cx="145" y="268" r="5" fill="#ef4444" opacity="0.6"/>
    789. 

  789.         <text x="120" y="290" text-anchor="middle" font-size="9" fill="#94a3b8">致病菌 ↑</text>
    790. 

  790. 

  791.         <!-- LPS arrow -->
    792. 

  792.         <defs>
    793. 

  793.           <marker id="arrowRed" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    794. 

  794.             <polygon points="0,0 10,4 0,8" fill="#ef4444"/>
    795. 

  795.           </marker>
    796. 

  796.           <marker id="arrowGreen" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    797. 

  797.             <polygon points="0,0 10,4 0,8" fill="#22c55e"/>
    798. 

  798.           </marker>
    799. 

  799.           <marker id="arrowBlue" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    800. 

  800.             <polygon points="0,0 10,4 0,8" fill="#3b82f6"/>
    801. 

  801.           </marker>
    802. 

  802.           <marker id="arrowPurple" markerWidth="10" markerHeight="8" refX="9" refY="4" orient="auto">
    803. 

  803.             <polygon points="0,0 10,4 0,8" fill="#8b5cf6"/>
    804. 

  804.           </marker>
    805. 

  805.         </defs>
    806. 

  806. 

  807.         <!-- LPS Leakage -->
    808. 

  808.         <line x1="230" y1="140" x2="340" y2="140" stroke="#ef4444" stroke-width="2.5" marker-end="url(#arrowRed)" stroke-dasharray="6,3"/>
    809. 

  809.         <text x="285" y="130" text-anchor="middle" font-size="9" fill="#ef4444">LPS 入血</text>
    810. 

  810. 

  811.         <!-- Systemic Circulation -->
    812. 

  812.         <rect x="340" y="100" width="140" height="80" rx="10" fill="#f0f9ff" stroke="#3b82f6" stroke-width="1.5"/>
    813. 

  813.         <text x="410" y="135" text-anchor="middle" font-size="12" font-weight="600" fill="#1d4ed8">血液系统</text>
    814. 

  814.         <text x="410" y="158" text-anchor="middle" font-size="9" fill="#64748b">系统性炎症 ↑</text>
    815. 

  815. 

  816.         <!-- Blood-Brain Barrier -->
    817. 

  817.         <line x1="480" y1="120" x2="580" y2="120" stroke="#f59e0b" stroke-width="2" marker-end="url(#arrowRed)"/>
    818. 

  818.         <text x="530" y="112" text-anchor="middle" font-size="9" fill="#f59e0b">BBB 通透性 ↑</text>
    819. 

  819. 

  820.         <!-- Brain side -->
    821. 

  821.         <rect x="580" y="40" width="240" height="220" rx="12" fill="#faf5ff" stroke="#8b5cf6" stroke-width="2"/>
    822. 

  822.         <text x="700" y="80" text-anchor="middle" font-size="14" font-weight="700" fill="#6b21a8">大脑 (Brain)</text>
    823. 

  823. 

  824.         <!-- Microglia -->
    825. 

  825.         <rect x="600" y="100" width="200" height="50" rx="8" fill="#ede9fe" stroke="#c4b5fd" stroke-width="1"/>
    826. 

  826.         <text x="700" y="130" text-anchor="middle" font-size="12" font-weight="600" fill="#5b21b6">小胶质细胞过度激活</text>
    827. 

  827. 

  828.         <!-- TLR4 -->
    829. 

  829.         <rect x="610" y="160" width="80" height="30" rx="6" fill="#fef2f2" stroke="#fca5a5" stroke-width="1"/>
    830. 

  830.         <text x="650" y="179" text-anchor="middle" font-size="10" fill="#b91c1c">TLR4 通路</text>
    831. 

  831.         <line x1="650" y1="130" x2="650" y2="160" stroke="#8b5cf6" stroke-width="1.5" marker-end="url(#arrowPurple)"/>
    832. 

  832. 

  833.         <!-- SCFAs arrow from gut to BBB -->
    834. 

  834.         <line x1="140" y1="130" x2="140" y2="30" stroke="#22c55e" stroke-width="1.5" marker-end="url(#arrowGreen)" stroke-dasharray="4,4"/>
    835. 

  835.         <text x="155" y="55" font-size="9" fill="#22c55e">SCFAs 保护信号 ↓</text>
    836. 

  836. 

  837.         <!-- Neuroinflammation output -->
    838. 

  838.         <rect x="610" y="200" width="180" height="50" rx="8" fill="#fee2e2" stroke="#fecaca" stroke-width="1"/>
    839. 

  839.         <text x="700" y="225" text-anchor="middle" font-size="11" font-weight="600" fill="#b91c1c">神经炎症 Neuroinflammation</text>
    840. 

  840.         <text x="700" y="242" text-anchor="middle" font-size="9" fill="#dc2626">Aβ↑ τ↑ Tau磷酸化↑</text>
    841. 

  841.         <line x1="700" y1="130" x2="700" y2="200" stroke="#ef4444" stroke-width="2" marker-end="url(#arrowRed)"/>
    842. 

  842. 

  843.         <!-- Molecules legend -->
    844. 

  844.         <rect x="30" y="310" width="790" height="80" rx="10" fill="#f8fafc" stroke="#e2e8f0" stroke-width="1"/>
    845. 

  845.         <text x="50" y="335" font-size="11" font-weight="600" fill="#334155">关键分子:</text>
    846. 

  846.         <line x1="130" y1="332" x2="170" y2="332" stroke="#ef4444" stroke-width="2"/>
    847. 

  847.         <text x="175" y="338" font-size="10" fill="#475569">LPS / 内毒素 —</text>
    848. 

  848.         <line x1="270" y1="332" x2="310" y2="332" stroke="#22c55e" stroke-width="2"/>
    849. 

  849.         <text x="315" y="338" font-size="10" fill="#475569">SCFAs / 丁酸 —</text>
    850. 

  850.         <line x1="410" y1="332" x2="450" y2="332" stroke="#8b5cf6" stroke-width="2"/>
    851. 

  851.         <text x="455" y="338" font-size="10" fill="#475569">TLR4 —</text>
    852. 

  852.         <line x1="530" y1="332" x2="570" y2="332" stroke="#3b82f6" stroke-width="2"/>
    853. 

  853.         <text x="575" y="338" font-size="10" fill="#475569">血脑屏障 BBB</text>
    854. 

  854.         <text x="50" y="362" font-size="10" fill="#94a3b8">路径: 菌群失调 → 肠漏 → LPS入血 → TLR4激活 → 小胶质细胞M1极化 → IL-1β/IL-6/TNF-α释放 → 神经炎症 → Aβ加速沉积 + tau过度磷酸化</text>
    855. 

  855.         <text x="50" y="380" font-size="10" fill="#94a3b8">保护路径: 健康菌群 → SCFAs(丁酸)↑ → 血脑屏障完整性↑ → 小胶质细胞维持M2保护表型 → Aβ有效清除</text>
    856. 

  856. 

  857.         <!-- Key connection arrows -->
    858. 

  858.         <line x1="230" y1="170" x2="340" y2="170" stroke="#ef4444" stroke-width="2.5" marker-end="url(#arrowRed)"/>
    859. 

  859.         <line x1="480" y1="140" x2="580" y2="140" stroke="#ef4444" stroke-width="2" marker-end="url(#arrowRed)"/>
    860. 

  860.       </svg>
    861. 

  861.       <div class="diagram-caption">
    862. 

  862.         <strong>▲ 图1：肠脑轴机制图</strong><br>
    863. 

  863.         肠道菌群失调→肠漏→LPS进入血液→系统性炎症→血脑屏障通透性↑→大脑小胶质细胞激活→神经炎症→AD<br>
    864. 

  864.         <strong>关键分子：</strong>SCFAs（丁酸）→调节小胶质细胞成熟和功能；LPS→通过TLR4激活小胶质细胞<br>
    865. 

  865.         <strong>参考文献：</strong>Lancet 2020 dementia commission doi:10.1016/S0140-6736(20)30367-6；Nature Neuroscience 2019
    866. 

  866.       </div>
    867. 

  867.     </div>
    868. 

  868.     
    869. 

  869.     <div class="citation-card">
    870. 

  870.       <div class="source">📊 AD患者肠道菌群特征</div>
    871. 

  871.       <div class="findings">
    872. 

  872.         AD患者肠道菌群特征：产丁酸菌（Akkermansia、Faecalibacterium）↓，产促炎菌（Escherichia、Shigella）↑<br>
    873. 

  873.         <strong>Nature Neuroscience 2019：</strong>AD患者的肠道菌群移植到小鼠→Aβ沉积↑、认知障碍↑（无菌小鼠对Aβ沉积抵抗）→肠道菌群是AD的因果因素
    874. 

  874.       </div>
    875. 

  875.     </div>
    876. 

  876. 

  877.     <div class="evidence-inline">
    878. 

  878.       <div class="evidence-title">🧬 证据截图 — 肠道菌群驱动AD的关键研究</div>
    879. 

  879.       <div class="evidence-image-wrap">
    880. 

  880.         <img src="../img/ref-screenshots/gut-microbiome-damage.jpg" alt="肠道菌群失调与AD关系截图" loading="lazy">
    881. 

  881.       </div>
    882. 

  882.       <div class="evidence-caption">
    883. 

  883.         <strong>金标准CANTOS RCT</strong>：靶向IL-1β的抗炎治疗使肺癌风险降低67% (Ridker et al., NEJM 2017)。这一发现首次在人类RCT层面验证了"炎症→疾病"的因果关系——AD的神经炎症同理。
    884. 

  884.       </div>
    885. 

  885.       <div class="evidence-translation">
    886. 

  886.         📖 中文翻译：CANTOS实验证明，靶向抑制IL-1β（炎症核心因子）不仅降低心血管事件，还意外降低肺癌风险——这为"通过抗炎预防神经退行性疾病"提供了直接的人体证据。AD的神经炎症机制与此同理：IL-1β是小胶质细胞激活后的核心致病因子。
    887. 

  887.       </div>
    888. 

  888.       <div class="evidence-meta">
    889. 

  889.         来源：Ridker PM et al. "Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis" · <a href="https://doi.org/10.1056/NEJMoa1707914" target="_blank" rel="noopener">NEJM 2017 doi:10.1056/NEJMoa1707914</a>
    890. 

  890.       </div>
    891. 

  891.     </div>
    892. 

  892.     
    893. 

  893.     <h3>3. 小胶质细胞的"双面角色"</h3>
    894. 

  894.     
    895. 

  895.     <div class="infographic">
    896. 

  896.       <div class="info-item">
    897. 

  897.         <div class="icon">🛡️</div>
    898. 

  898.         <h4>保护状态</h4>
    899. 

  899.         <p>A1表型<br>清除Aβ碎片<br>突触修剪</p>
    900. 

  900.       </div>
    901. 

  901.       <div class="info-item">
    902. 

  902.         <div class="icon">⚡</div>
    903. 

  903.         <h4>破坏状态</h4>
    904. 

  904.         <p>持续激活<br>IL-1β/IL-6/TNF-α<br>tau磷酸化</p>
    905. 

  905.       </div>
    906. 

  906.       <div class="info-item">
    907. 

  907.         <div class="icon">🧬</div>
    908. 

  908.         <h4>TREM2突变</h4>
    909. 

  909.         <p>吞噬能力↓<br>Aβ清除↓<br>风险↑3-4倍</p>
    910. 

  910.       </div>
    911. 

  911.       <div class="info-item">
    912. 

  912.         <div class="icon">🎯</div>
    913. 

  913.         <h4>治疗靶点</h4>
    914. 

  914.         <p>抗炎治疗<br>小胶质细胞状态<br>神经炎症</p>
    915. 

  915.       </div>
    916. 

  916.     </div>
    917. 

  917.     
    918. 

  918.     <div class="evidence-inline">
    919. 

  919.       <div class="evidence-title">🧠 证据截图 — 小胶质细胞在AD中的双面角色</div>
    920. 

  920.       <div class="evidence-image-wrap">
    921. 

  921.         <img src="../img/ref-screenshots/ref3_nature_stt.png" alt="Nature综述：神经炎症与AD机制截图" loading="lazy">
    922. 

  922.       </div>
    923. 

  923.       <div class="evidence-caption">
    924. 

  924.         <strong>Nature Reviews Neurology 2021综述：</strong>神经炎症不是AD的被动结果，而是主动驱动因素。小胶质细胞从稳态向"疾病相关小胶质细胞(DAM)"表型转变是AD早期的关键事件——发生在Aβ大量沉积之前。TREM2突变携带者的小胶质细胞无法有效清除Aβ，且更容易进入破坏性的促炎状态。
    925. 

  925.       </div>
    926. 

  926.       <div class="evidence-translation">
    927. 

  927.         📖 中文翻译：小胶质细胞从保护者变为破坏者的过程是AD发病的核心环节。在Aβ斑块形成之前，炎症信号已经启动了小胶质细胞的功能转变。这意味着抗炎干预的最佳时机可能远在认知症状出现之前。
    928. 

  928.       </div>
    929. 

  929.       <div class="evidence-meta">
    930. 

  930.         来源：Leng F, Edison P. "Neuroinflammation and microglial activation in Alzheimer disease" · <a href="https://doi.org/10.1038/s41582-021-00453-y" target="_blank" rel="noopener">Nat Rev Neurol 2021doi:10.1038/s41582-021-00453-y</a>
    931. 

  931.       </div>
    932. 

  932.     </div>
    933. 

  933. 

  934.     <h3>4. 全身慢性炎症→神经退行性变</h3>
    935. 

  935.     
    936. 

  936.     <div class="two-col-grid-3">
    937. 

  937.       <div class="tip-card purple">
    938. 

  938.         <div class="tip-icon">🧬</div>
    939. 

  939.         <h4>CRP/IL-6水平升高</h4>
    940. 

  940.         <p>与AD风险正相关（meta分析：IL-6↑1SD→AD风险↑约30%）</p>
    941. 

  941.       </div>
    942. 

  942.       <div class="tip-card orange">
    943. 

  943.         <div class="icon">🫀</div>
    944. 

  944.         <h4>心血管病</h4>
    945. 

  945.         <p>动脉硬化→大脑慢性低灌注→血脑屏障功能↓→神经炎症↑</p>
    946. 

  946.       </div>
    947. 

  947.       <div class="tip-card blue">
    948. 

  948.         <div class="icon">🥊</div>
    949. 

  949.         <h4>糖尿病/胰岛素抵抗</h4>
    950. 

  950.         <p>AGEs积累→tau磷酸化↑→认知下降</p>
    951. 

  951.       </div>
    952. 

  952.       <div class="tip-card teal">
    953. 

  953.         <div class="icon">😴</div>
    954. 

  954.         <h4>睡眠剥夺</h4>
    955. 

  955.         <p>glymphatic系统↓→Aβ和tau的夜间清除↓→Aβ积累加速</p>
    956. 

  956.       </div>
    957. 

  957.     </div>
    958. 

  958.     
    959. 

  959.     <h3>5. 生活方式与AD风险</h3>
    960. 

  960.     
    961. 

  961.     <div class="tip-grid">
    962. 

  962.       <div class="tip-card green">
    963. 

  963.         <div class="tip-icon">🏃</div>
    964. 

  964.         <h4>缺乏运动</h4>
    965. 

  965.         <p>是最强可控风险因素之一（久坐→脑血流↓→神经炎症↑）</p>
    966. 

  966.       </div>
    967. 

  967.       <div class="tip-card orange">
    968. 

  968.         <div class="icon">🤝</div>
    969. 

  969.         <h4>社交孤立</h4>
    970. 

  970.         <p>小胶质细胞炎症模式改变→AD风险↑</p>
    971. 

  971.       </div>
    972. 

  972.       <div class="tip-card purple">
    973. 

  973.         <div class="icon">😤</div>
    974. 

  974.         <h4>抑郁/慢性应激</h4>
    975. 

  975.         <p>皮质醇↑→海马神经元萎缩</p>
    976. 

  976.       </div>
    977. 

  977.     </div>
    978. 

  978.     
    979. 

  979.     <h3>6. 氧化应激在AD中的作用</h3>
    980. 

  980.     
    981. 

  981.     <div class="highlight-box orange">
    982. 

  982.       <p><strong>Aβ诱导线粒体ROS↑→氧化应激→tau磷酸化↑→神经细胞死亡。</strong>大脑是体内耗氧量最高的器官（约占全身20%），抗氧化能力相对较弱。</p>
    983. 

  983.       <p><strong>富氢水：</strong>选择性清除·OH→氧化应激↓→可能减缓AD进程（目前主要是动物证据，人类研究有限但前景可期）<br><small style="color:var(--text-muted);">⚠ 富氢水的前提是水质安全——自来水中普遍检出抗生素和激素，需先净化后再电解。 → <a href="tap-water-pollution.html" style="color:var(--accent);">自来水中的隐形威胁</a></small></p>
    984. 

  984.     </div>
    985. 

  985. 

  986.     <div class="evidence-inline">
    987. 

  987.       <div class="evidence-title">💧 证据截图 — 富氢水抗氧化神经保护研究</div>
    988. 

  988.       <div class="evidence-image-wrap">
    989. 

  989.         <img src="../img/ref-screenshots/ref12_pmc_hydrogen_water.png" alt="氢水神经保护研究截图" loading="lazy">
    990. 

  990.       </div>
    991. 

  991.       <div class="evidence-caption">
    992. 

  992.         <strong>PMC综述 2024：</strong>溶解氢(H₂)选择性清除羟基自由基(·OH)和过氧亚硝酸盐(ONOO⁻)，不干扰有益ROS信号分子。动物模型显示氢水可减轻Aβ诱导的氧化损伤和神经炎症。
    993. 

  993.       </div>
    994. 

  994.       <div class="evidence-translation">
    995. 

  995.         📖 中文翻译：溶解氢能够选择性清除最具破坏性的自由基·OH，而不影响低毒性的O₂⁻和H₂O₂等正常信号分子——这使其成为理想的抗氧化剂，尤其适用于AD这类氧化应激主导的神经退行性疾病。
    996. 

  996.       </div>
    997. 

  997.       <div class="evidence-meta">
    998. 

  998.         来源：PMC Hydrogen Water Research · <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10816194/" target="_blank" rel="noopener">PMC10816194</a>
    999. 

  999.       </div>
    1000. 

  1000.     </div>
    1001. 

  1001.     
    1002. 

  1002.     <div class="warning">
    1003. 

  1003.       <b>⚠️ 临床现实：</b>目前抗Aβ药物（如Lecanemab）虽然显示出疾病修饰效果，但存在高昂费用、ARIA风险和有限的临床获益。针对神经炎症和肠脑轴的治疗策略显示出更大的潜力。
    1004. 

  1004.     </div>
    1005. 

  1005.   </div>
    1006. 

  1006. </section>
    1007. 

  1007. 

  1008. <!-- ===== SECTION: STEP 01 ===== -->
    1009. 

  1009. <section id="step1" class="alt">
    1010. 

  1010.   <div class="container">
    1011. 

  1011.     <h2>🎯 STEP 01 炎症评估 → 在神经炎症扩散前发现风险</h2>
    1012. 

  1012.     
    1013. 

  1013.     <div class="data-grid">
    1014. 

  1014.       <div class="data-card">
    1015. 

  1015.         <div class="big-number blue">60</div>
    1016. 

  1016.         <div class="unit">岁及以上</div>
    1017. 

  1017.         <div class="desc">每年进行MoCA评估并检测hsCRP</div>
    1018. 

  1018.       </div>
    1019. 

  1019.       <div class="data-card">
    1020. 

  1020.         <div class="big-number green">15年</div>
    1021. 

  1021.         <div class="unit">症状前</div>
    1022. 

  1022.         <div class="desc">病理开始积累</div>
    1023. 

  1023.       </div>
    1024. 

  1024.       <div class="data-card">
    1025. 

  1025.         <div class="big-number orange">3-4倍</div>
    1026. 

  1026.         <div class="unit">高危人群</div>
    1027. 

  1027.         <div class="desc">APOE ε4携带者风险</div>
    1028. 

  1028.       </div>
    1029. 

  1029.       <div class="data-card">
    1030. 

  1030.         <div class="big-number purple">10-20年</div>
    1031. 

  1031.         <div class="unit">病理积累期</div>
    1032. 

  1032.         <div class="desc">从无症状到症状</div>
    1033. 

  1033.       </div>
    1034. 

  1034.     </div>
    1035. 

  1035.     
    1036. 

  1036.     <h3>1.1 认知筛查</h3>
    1037. 

  1037.     <p>MoCA（Montreal Cognitive Assessment，比MMSE更敏感）≥60岁每年一次。</p>
    1038. 

  1038.     
    1039. 

  1039.     <h3>1.2 肠道菌群检测</h3>
    1040. 

  1040.     <p>产丁酸菌丰度↓是神经炎症风险的肠道标志。</p>
    1041. 

  1041.     
    1042. 

  1042.     <h3>1.3 Aβ/Tau生物标志物（研究级）</h3>
    1043. 

  1043.     <p>脑脊液Aβ42↓、t-tau/p-tau↑；PET淀粉样蛋白扫描（早期诊断金标准，但费用高）</p>
    1044. 

  1044.     
    1045. 

  1045.     <h3>1.4 高危人群</h3>
    1046. 

  1046.     <ul>
    1047. 

  1047.       <li>直系亲属有AD病史</li>
    1048. 

  1048.       <li>APOE ε4携带者（遗传风险×3-4倍）</li>
    1049. 

  1049.       <li>心血管疾病患者</li>
    1050. 

  1050.       <li>抑郁/焦虑患者</li>
    1051. 

  1051.     </ul>
    1052. 

  1052.     
    1053. 

  1053.     <h3>1.5 心血管健康评估</h3>
    1054. 

  1054.     <p>颈动脉IMT厚度→脑血流灌注评估→神经退行性变风险</p>
    1055. 

  1055.     
    1056. 

  1056.     <div class="highlight-box blue">
    1057. 

  1057.       <p><strong>早期识别的重要性：</strong>一旦发现病理改变，可以在症状出现前20年内进行干预，阻止或减缓疾病进展。</p>
    1058. 

  1058.     </div>
    1059. 

  1059.   </div>
    1060. 

  1060. </section>
    1061. 

  1061. 

  1062. <!-- ===== SECTION: STEP 02 ===== -->
    1063. 

  1063. <section id="step2">
    1064. 

  1064.   <div class="container">
    1065. 

  1065.     <h2>🎯 STEP 02 阻断源头 → 修复肠漏，熄灭神经炎症</h2>
    1066. 

  1066.     
    1067. 

  1067.     <div class="highlight-box purple">
    1068. 

  1068.       <p><strong>核心策略转变：</strong>神经炎症的根源在肠道——肠漏→LPS入血→激活TLR4→小胶质细胞活化→神经炎症。修复肠屏障、调节肠道菌群是熄灭神经炎症的一线策略。目标是阻止/减缓病理进展。</p>
    1069. 

  1069.     </div>
    1070. 

  1070.     
    1071. 

  1071.     <h3>2.1 药物（对症）</h3>
    1072. 

  1072.     <p>胆碱酯酶抑制剂（多奈哌齐、卡巴拉汀）→改善神经递质，但不影响病程。</p>
    1073. 

  1073.     
    1074. 

  1074.     <h3>2.2 生活方式干预（抗炎）</h3>
    1075. 

  1075.     
    1076. 

  1076.     <div class="infographic">
    1077. 

  1077.       <div class="info-item">
    1078. 

  1078.         <div class="icon">🍈</div>
    1079. 

  1079.         <h4>地中海/MIND饮食</h4>
    1080. 

  1080.         <p>与AD风险↓35-40%相关（蔬菜+浆果+橄榄油+鱼）</p>
    1081. 

  1081.       </div>
    1082. 

  1082.       <div class="info-item">
    1083. 

  1083.         <div class="icon">🧠</div>
    1084. 

  1084.         <h4>认知储备</h4>
    1085. 

  1085.         <p>教育、阅读、学习新技能→症状更晚出现</p>
    1086. 

  1086.       </div>
    1087. 

  1087.       <div class="info-item">
    1088. 

  1088.         <div class="icon">💊</div>
    1089. 

  1089.         <h4>抗炎补充剂</h4>
    1090. 

  1090.         <p>Omega-3、<a href="turmeric.html">姜黄素</a>、绿茶提取物</p>
    1091. 

  1091.       </div>
    1092. 

  1092.     </div>
    1093. 

  1093.     
    1094. 

  1094.     <div class="warning">
    1095. 

  1095.       <b>⚠️ 治疗现状：</b>目前抗Aβ药物（如Lecanemab、Donanemab）显示疾病修饰效果，但费用高、需静脉输注、存在ARIA风险。
    1096. 

  1096.     </div>
    1097. 

  1097.   </div>
    1098. 

  1098. </section>
    1099. 

  1099. 

  1100. <!-- ===== SECTION: STEP 03 ===== -->
    1101. 

  1101. <section id="step3" class="alt">
    1102. 

  1102.   <div class="container">
    1103. 

  1103.     <h2>🎯 STEP 03 抗炎干预 → 保护小胶质细胞 + 改善肠脑轴</h2>
    1104. 

  1104.     
    1105. 

  1105.     <h3>3.1 运动（最强抗炎干预）</h3>
    1106. 

  1106.     <p>有氧运动→BDNF（脑源性神经营养因子）↑→海马神经元新生；每周150分钟中等强度运动→认知功能改善证据充分。</p>
    1107. 

  1107.     
    1108. 

  1108.     <h3>3.2 睡眠</h3>
    1109. 

  1109.     <p>7-9小时/天，睡眠呼吸暂停（OSAS）→间歇性低氧→神经炎症→AD风险↑2-3倍（治疗OSAS可改善认知）</p>
    1110. 

  1110.     
    1111. 

  1111.     <h3>3.3 饮食抗炎</h3>
    1112. 

  1112.     
    1113. 

  1113.     <div class="two-col-grid">
    1114. 

  1114.       <div class="citation-card" style="border-left:4px solid #2d7d9a;">
    1115. 

  1115.         <div class="source">🐟 Omega-3</div>
    1116. 

  1116.         <div class="findings">
    1117. 

  1117.           EPA/DHA→消退素（resolvins）→炎症消退<br>
    1118. 

  1118.           每周2-3次三文鱼、鲑鱼或鱼油补充剂
    1119. 

  1119.         </div>
    1120. 

  1120.       </div>
    1121. 

  1121.       <div class="citation-card" style="border-left:4px solid #dd6b20;">
    1122. 

  1122.         <div class="source">🚫 限制精制碳水</div>
    1123. 

  1123.         <div class="findings">
    1124. 

  1124.           血糖波动↓→AGEs↓→tau磷酸化↓<br>
    1125. 

  1125.           用全谷物、豆类代替白面包、糖果
    1126. 

  1126.         </div>
    1127. 

  1127.       </div>
    1128. 

  1128.     </div>
    1129. 

  1129.     
    1130. 

  1130.     <h3>3.4 社交和认知刺激</h3>
    1131. 

  1131.     <p>维持认知储备（教育、阅读、学习新技能）→即使有病理学改变，认知症状更晚出现（"认知储备"理论）</p>
    1132. 

  1132.     
    1133. 

  1133.     <h3>3.5 富氢水</h3>
    1134. 

  1134.     <p>抗氧化→神经炎症↓→小胶质细胞从破坏表型向保护表型转变（研究前景）</p>
    1135. 

  1135.     
    1136. 

  1136.     <h3>3.6 肠道菌群优化</h3>
    1137. 

  1137.     
    1138. 

  1138.     <div class="tip-grid">
    1139. 

  1139.       <div class="tip-card green">
    1140. 

  1140.         <div class="tip-icon">🥬</div>
    1141. 

  1141.         <h4>高纤维饮食</h4>
    1142. 

  1142.         <p>→产丁酸菌↑→丁酸→肠脑轴抗炎→小胶质细胞保护功能恢复</p>
    1143. 

  1143.       </div>
    1144. 

  1144.       <div class="tip-card blue">
    1145. 

  1145.         <div class="icon">🧫</div>
    1146. 

  1146.         <h4>益生菌</h4>
    1147. 

  1147.         <p>特定菌株（如双歧杆菌、乳杆菌）可改善肠道屏障，减少内毒素入血</p>
    1148. 

  1148.       </div>
    1149. 

  1149.       <div class="tip-card purple">
    1150. 

  1150.         <div class="icon">🌾</div>
    1151. 

  1151.         <h4>益生元</h4>
    1152. 

  1152.         <p>低聚果糖、水苏糖→促进有益菌生长，抑制有害菌</p>
    1153. 

  1153.       </div>
    1154. 

  1154.     </div>
    1155. 

  1155.     
    1156. 

  1156.     <div class="highlight-box green">
    1157. 

  1157.       <p><strong>干预重点：</strong>运动、睡眠、饮食和肠道健康是预防AD的关键因素。针对小胶质细胞和神经炎症的治疗策略显示出更大的前景。</p>
    1158. 

  1158.     </div>
    1159. 

  1159.   </div>
    1160. 

  1160. </section>
    1161. 

  1161. 

  1162. <!-- ===== SECTION: STEP 04 ===== -->
    1163. 

  1163. <section id="step4">
    1164. 

  1164.   <div class="container">
    1165. 

  1165.     <h2>🎯 STEP 04 效果追踪</h2>
    1166. 

  1166.     
    1167. 

  1167.     <div class="two-col-grid">
    1168. 

  1168.       <div class="data-card">
    1169. 

  1169.         <div class="big-number blue">3分</div>
    1170. 

  1170.         <div class="unit">/年</div>
    1171. 

  1171.         <div class="desc">MoCA变化（下降≥3分/年提示进展快）</div>
    1172. 

  1172.       </div>
    1173. 

  1173.       <div class="data-card">
    1174. 

  1174.         <div class="big-number green">产丁酸菌</div>
    1175. 

  1175.         <div class="unit">丰度趋势</div>
    1176. 

  1176.         <div class="desc">肠道菌群改善指标</div>
    1177. 

  1177.       </div>
    1178. 

  1178.       <div class="data-card">
    1179. 

  1179.         <div class="big-number orange">hsCRP/IL-6</div>
    1180. 

  1180.         <div class="unit">炎症水平</div>
    1181. 

  1181.         <div class="desc">全身炎症指标</div>
    1182. 

  1182.       </div>
    1183. 

  1183.       <div class="data-card">
    1184. 

  1184.         <div class="big-number purple">ADL/IADL</div>
    1185. 

  1185.         <div class="unit">功能独立性</div>
    1186. 

  1186.         <div class="desc">日常生活能力评估</div>
    1187. 

  1187.       </div>
    1188. 

  1188.     </div>
    1189. 

  1189.     
    1190. 

  1190.     <h3>4.1 认知评估</h3>
    1191. 

  1191.     <p>MoCA年度变化（下降≥3分/年提示进展快）</p>
    1192. 

  1192.     
    1193. 

  1193.     <h3>4.2 肠道菌群评估</h3>
    1194. 

  1194.     <p>产丁酸菌丰度变化趋势</p>
    1195. 

  1195.     
    1196. 

  1196.     <h3>4.3 炎症评估</h3>
    1197. 

  1197.     <p>hsCRP/IL-6水平</p>
    1198. 

  1198.     
    1199. 

  1199.     <h3>4.4 功能评估</h3>
    1200. 

  1200.     <p>ADL（日常生活能力）vs IADL（工具性日常生活能力）</p>
    1201. 

  1201.     
    1202. 

  1202.     <div class="highlight-box blue">
    1203. 

  1203.       <p><strong>评估工具：</strong>综合评估包括认知测试、肠道菌群检测、炎症标志物和日常生活能力评估，以全面了解干预效果。</p>
    1204. 

  1204.     </div>
    1205. 

  1205.   </div>
    1206. 

  1206. </section>
    1207. 

  1207. 

  1208. <!-- ===== SECTION: STEP 05 ===== -->
    1209. 

  1209. <section id="step5" class="alt">
    1210. 

  1210.   <div class="container">
    1211. 

  1211.     <h2>🎯 STEP 05 持续优化</h2>
    1212. 

  1212.     
    1213. 

  1213.     <h3>5.1 认知康复</h3>
    1214. 

  1214.     <p>非药物干预（现实定向、回忆疗法、认知训练）→维持认知功能</p>
    1215. 

  1215.     
    1216. 

  1216.     <h3>5.2 家庭支持</h3>
    1217. 

  1217.     
    1218. 

  1218.     <div class="tip-grid">
    1219. 

  1219.       <div class="tip-card purple">
    1220. 

  1220.         <div class="tip-icon">👨‍👩‍👧‍👦</div>
    1221. 

  1221.         <h4>照护者教育</h4>
    1222. 

  1222.         <p>减少激越/攻击性行为的管理、行为疗法</p>
    1223. 

  1223.       </div>
    1224. 

  1224.       <div class="tip-card orange">
    1225. 

  1225.         <div class="icon">🔒</div>
    1226. 

  1226.         <h4>防走失措施</h4>
    1227. 

  1227.         <p>定位手环、门禁系统、家庭安全评估</p>
    1228. 

  1228.       </div>
    1229. 

  1229.     </div>
    1230. 

  1230.     
    1231. 

  1231.     <h3>5.3 未来方向</h3>
    1232. 

  1232.     
    1233. 

  1233.     <div class="infographic">
    1234. 

  1234.       <div class="info-item">
    1235. 

  1235.         <div class="icon">💊</div>
    1236. 

  1236.         <h4>Lecanemab</h4>
    1237. 

  1237.         <p>抗Aβ单克隆抗体<br>疾病修饰效果</p>
    1238. 

  1238.       </div>
    1239. 

  1239.       <div class="info-item">
    1240. 

  1240.         <div class="icon">🧬</div>
    1241. 

  1241.         <h4>Donanemab</h4>
    1242. 

  1242.         <p>另一款抗Aβ抗体<br>临床试验中</p>
    1243. 

  1243.       </div>
    1244. 

  1244.       <div class="info-item">
    1245. 

  1245.         <div class="icon">🎯</div>
    1246. 

  1246.         <h4>小胶质细胞</h4>
    1247. 

  1247.         <p>抗炎治疗<br>保护表型</p>
    1248. 

  1248.       </div>
    1249. 

  1249.       <div class="info-item">
    1250. 

  1250.         <div class="icon">🦠</div>
    1251. 

  1251.         <h4>肠脑轴</h4>
    1252. 

  1252.         <p>益生菌/益生元<br>肠道健康</p>
    1253. 

  1253.       </div>
    1254. 

  1254.     </div>
    1255. 

  1255.     
    1256. 

  1256.     <div class="highlight-box teal">
    1257. 

  1257.       <p><strong>未来展望：</strong>针对小胶质细胞和肠脑轴的治疗策略显示出更大的前景。早期诊断和积极的生活方式干预是预防AD的关键。</p>
    1258. 

  1258.     </div>
    1259. 

  1259.   </div>
    1260. 

  1260. </section>
    1261. 

  1261. 

  1262. <!-- ===== SECTION: TREATMENT ANALYSIS ===== -->
    1263. 

  1263. <section id="treatment">
    1264. 

  1264.   <div class="container">
    1265. 

  1265.     <div class="section-tag gold" style="color:var(--gold);background:var(--gold-light);padding:0.3rem 0.8rem;border-radius:100px;display:inline-block;font-size:0.75rem;font-weight:700;margin-bottom:0.8rem;">💊 对症下药——药物在"治"什么？</div>
    1266. 

  1266.     <h2 style="font-size:1.4rem;font-weight:700;margin-bottom:0.8rem;">主流AD治疗分析——药物在"治"什么？</h2>
    1267. 

  1267.     <p style="color:var(--text-secondary);font-size:0.95rem;line-height:1.8;margin-bottom:1.5rem;">主流AD治疗的核心逻辑：<strong>症状出现了 → 补充丧失的神经递质 / 试图清除淀粉样蛋白</strong>。胆碱酯酶抑制剂把突触间隙里剩余的乙酰胆碱多留一会儿、美金刚减少谷氨酸的过度刺激——它们可以暂时改善认知症状几个月，但<strong>不能阻止疾病进展</strong>。抗Aβ单抗终于触及病理蛋白，但对已发病者的效果有限。以下逐项分析。</p>
    1268. 

  1268. 

  1269.     <div class="grid-2" style="display:grid;grid-template-columns:1fr 1fr;gap:1rem;">
    1270. 

  1270.       <div class="card card-accent">
    1271. 

  1271.         <h3>💊 胆碱酯酶抑制剂（多奈哌齐、卡巴拉汀）</h3>
    1272. 

  1272.         <p><strong>机制：</strong>抑制乙酰胆碱酯酶→增加突触间隙ACh浓度——代偿性改善认知信号传递</p>
    1273. 

  1273.         <p><strong>临床效果：</strong>ADAS-cog评分改善2-3分（vs安慰剂），相当于延缓认知衰退6-12个月。≠逆转疾病</p>
    1274. 

  1274.         <p><strong>治愈/反弹：</strong>停药后认知评分在2-4周内下降至治疗前水平。无疾病修饰作用</p>
    1275. 

  1275.         <div class="evidence-box" style="margin-top:0.5rem;padding:0.6rem;">
    1276. 

  1276.           <p style="font-size:0.82rem;font-weight:700;color:var(--accent);margin-bottom:0.2rem;">❌ 未被触及的根源：</p>
    1277. 

  1277.           <p style="font-size:0.8rem;">只增加神经递质可用性，不改变神经炎症驱动的小胶质细胞M1极化→Aβ沉积→tau磷酸化这一核心病理链</p>
    1278. 

  1278.         </div>
    1279. 

  1279.       </div>
    1280. 

  1280. 

  1281.       <div class="card card-blue">
    1282. 

  1282.         <h3>🧠 NMDA拮抗剂（美金刚）</h3>
    1283. 

  1283.         <p><strong>机制：</strong>非竞争性NMDA受体拮抗剂——减少谷氨酸过度刺激导致的神经元兴奋性毒性</p>
    1284. 

  1284.         <p><strong>临床效果：</strong>中重度AD中认知功能和行为症状有轻度改善。效果与多奈哌齐相当（SMD≈0.2-0.3）</p>
    1285. 

  1285.         <p><strong>治愈/反弹：</strong>停药后4-8周效果消失。同样无疾病修饰作用</p>
    1286. 

  1286.         <div class="evidence-box blue" style="margin-top:0.5rem;padding:0.6rem;">
    1287. 

  1287.           <p style="font-size:0.82rem;font-weight:700;color:var(--blue);margin-bottom:0.2rem;">❌ 未被触及的根源：</p>
    1288. 

  1288.           <p style="font-size:0.8rem;">谷氨酸毒性是神经元死亡的终末通路之一，但驱动小胶质细胞过度激活的肠脑轴炎症（LPS→TLR4→IL-1β/TNF-α）未被干预</p>
    1289. 

  1289.         </div>
    1290. 

  1290.       </div>
    1291. 

  1291. 

  1292.       <div class="card card-teal">
    1293. 

  1293.         <h3>🎯 抗Aβ单抗（仑卡奈单抗 Lecanemab / 多奈单抗 Donanemab）</h3>
    1294. 

  1294.         <p><strong>机制：</strong>人源化单克隆抗体靶向Aβ聚集物（原纤维/斑块）——通过FcγR介导的小胶质细胞吞噬清除Aβ</p>
    1295. 

  1295.         <p><strong>临床效果：</strong>Clarity AD(NEJM 2023, n=1,795)：仑卡奈单抗18个月使CDR-SB评分减缓进展27%。Donanemab(TRAILBLAZER-ALZ 2, JAMA 2023)：减缓认知下降35%</p>
    1296. 

  1296.         <p><strong>治愈/反弹：</strong>停药后Aβ沉积可能重新积聚。ARIA（淀粉样蛋白相关影像异常）发生率约12-40%——包括脑水肿和微出血</p>
    1297. 

  1297.         <div class="evidence-box green" style="margin-top:0.5rem;padding:0.6rem;">
    1298. 

  1298.           <p style="font-size:0.82rem;font-weight:700;color:var(--teal);margin-bottom:0.2rem;">❌ 未被触及的根源：</p>
    1299. 

  1299.           <p style="font-size:0.8rem;">Aβ是结果不是原因——Aβ沉积是小胶质细胞应对慢性炎症的"应急响应产物"。清除了Aβ，但驱动Aβ产生的神经炎症环境没有改变</p>
    1300. 

  1300.         </div>
    1301. 

  1301.       </div>
    1302. 

  1302. 

  1303.       <div class="card card-purple">
    1304. 

  1304.         <h3>🛡️ 抗tau疗法与联合治疗（在研）</h3>
    1305. 

  1305.         <p><strong>机制：</strong>靶向tau蛋白的单抗/疫苗——阻止tau聚集和朊病毒样传播。BIIB080（反义寡核苷酸）直接减少tau mRNA表达</p>
    1306. 

  1306.         <p><strong>临床效果：</strong>截至2026年尚无获批的抗tau药物。II期试验显示脑脊液tau降低30-50%，但临床结局尚未达显著性</p>
    1307. 

  1307.         <p><strong>治愈/反弹：</strong>尚在研究阶段</p>
    1308. 

  1308.         <div class="evidence-box purple" style="margin-top:0.5rem;padding:0.6rem;">
    1309. 

  1309.           <p style="font-size:0.82rem;font-weight:700;color:var(--purple);margin-bottom:0.2rem;">❌ 未被触及的根源：</p>
    1310. 

  1310.           <p style="font-size:0.8rem;">tau过度磷酸化是神经炎症的下游事件——小胶质细胞M1极化释放IL-1β/TNF-α/IL-6，激活p38 MAPK→tau激酶。清tau不清炎症，治标不治本</p>
    1311. 

  1311.         </div>
    1312. 

  1312.       </div>
    1313. 

  1313.     </div>
    1314. 

  1314. 

  1315.     <div class="evidence-box" style="margin-top:2rem;background:var(--gold-light);border-color:var(--gold);">
    1316. 

  1316.       <p><strong>核心结论：</strong>多奈哌齐/美金刚改善症状（治标）、仑卡奈单抗清除Aβ（治标）、抗tau疗法还在路上——<strong>没有一种获批药物修复肠脑轴、熄灭神经炎症这个上游</strong>。Aβ和tau是细胞对炎症的应激产物，不是初始驱动者。即便仑卡奈单抗清除了Aβ斑块，肠漏→LPS入血→小胶质细胞M1极化的链条仍然在运转。</p>
    1317. 

  1317.       <p style="margin-top:0.5rem;font-size:0.85rem;">这些治疗在改善患者生活质量上意义重大。本文不是在否定药物——而是在追问：<strong>Aβ清除了，但神经炎症停了吗？</strong></p>
    1318. 

  1318.     </div>
    1319. 

  1319.   </div>
    1320. 

  1320. </section>
    1321. 

  1321. 

  1322. <!-- ===== SECTION: REFERENCES ===== -->
    1323. 

  1323. <section id="references">
    1324. 

  1324.   <div class="container">
    1325. 

  1325.     <h2>📚 参考文献</h2>
    1326. 

  1326.     
    1327. 

  1327.     <ol class="ref-list">
    1328. 

  1328.       <li>
    1329. 

  1329.         <strong>CANTOS Trial</strong> — Ridker et al. · NEJM · 2017 · <a href="https://doi.org/10.1056/NEJMoa1707914" target="_blank" rel="noopener">doi:10.1056/NEJMoa1707914</a>
    1330. 

  1330.         <span class="translation">CANTOS里程碑RCT：靶向IL-1β的抗炎治疗使肺癌风险降低67%，验证了"熄灭炎症之火"的神经保护潜力——神经炎症同样是AD的核心机制</span>
    1331. 

  1331.       </li>
    1332. 

  1332.       <li>
    1333. 

  1333.         <strong>Lancet 2020 dementia commission</strong> — <a href="https://doi.org/10.1016/S0140-6736(20)30367-6" target="_blank" rel="noopener">doi:10.1016/S0140-6736(20)30367-6</a>
    1334. 

  1334.         <span class="translation">《柳叶刀》2020年痴呆病理生理学委员会报告</span>
    1335. 

  1335.       </li>
    1336. 

  1336.       <li>
    1337. 

  1337.         <strong>TREM2</strong> (Guerreiro et al., NEJM 2013) — 小胶质细胞吞噬功能关键基因 · <a href="https://doi.org/10.1056/NEJMoa1211851" target="_blank" rel="noopener">doi:10.1056/NEJMoa1211851</a>
    1338. 

  1338.         <span class="translation">TREM2基因突变导致小胶质细胞功能障碍，AD风险升高3-4倍</span>
    1339. 

  1339.       </li>
    1340. 

  1340.       <li>
    1341. 

  1341.         <strong>Nature Neuroscience 2019</strong> (Kim et al.) — 肠道菌群移植驱动AD病理 · <a href="https://doi.org/10.1038/s41593-019-0456-6" target="_blank" rel="noopener">doi:10.1038/s41593-019-0456-6</a>
    1342. 

  1342.         <span class="translation">《自然神经科学》2019年，AD患者肠道菌群移植到小鼠模型导致Aβ沉积增加</span>
    1343. 

  1343.       </li>
    1344. 

  1344.       <li>
    1345. 

  1345.         <strong>NEJM 2023</strong> (van Dyck et al.) — Lecanemab III期临床试验 · <a href="https://doi.org/10.1056/NEJMoa2212948" target="_blank" rel="noopener">doi:10.1056/NEJMoa2212948</a>
    1346. 

  1346.         <span class="translation">《新英格兰医学杂志》2023年，抗Aβ单克隆抗体Lecanemab疾病修饰效果</span>
    1347. 

  1347.       </li>
    1348. 

  1348.       <li>
    1349. 

  1349.         <strong>Cell 2017</strong> (Keren-Shaul et al.) — DAM小胶质细胞亚型 · <a href="https://doi.org/10.1016/j.cell.2017.05.018" target="_blank" rel="noopener">doi:10.1016/j.cell.2017.05.018</a>
    1350. 

  1350.         <span class="translation">《细胞》2017年，疾病相关小胶质细胞(DAM)在AD中从稳态到神经退行表型的转变</span>
    1351. 

  1351.       </li>
    1352. 

  1352.       <li>
    1353. 

  1353.         <strong>Nature 2021</strong> (Leng & Edison) — 神经炎症在AD中的核心作用 · <a href="https://doi.org/10.1038/s41582-021-00453-y" target="_blank" rel="noopener">doi:10.1038/s41582-021-00453-y</a>
    1354. 

  1354.         <span class="translation">《自然综述·神经病学》2021年，神经炎症是AD的关键驱动机制而非后果</span>
    1355. 

  1355.       </li>
    1356. 

  1356.       <li>
    1357. 

  1357.         <strong>Science Advances 2022</strong> (Chandra et al.) — 肠脑轴与神经退行 · <a href="https://doi.org/10.1126/sciadv.abo3029" target="_blank" rel="noopener">doi:10.1126/sciadv.abo3029</a>
    1358. 

  1358.         <span class="translation">肠道菌群代谢产物调控小胶质细胞介导的AD神经炎症</span>
    1359. 

  1359.       </li>
    1360. 

  1360.       <li>
    1361. 

  1361.         <strong>JAMA Neurology 2023</strong> (Dhana et al.) — MIND饮食与AD风险 · <a href="https://doi.org/10.1001/jamaneurol.2023.0992" target="_blank" rel="noopener">doi:10.1001/jamaneurol.2023.0992</a>
    1362. 

  1362.         <span class="translation">《JAMA神经病学》2023年，MIND饮食与地中海饮食对认知衰退的预防效果</span>
    1363. 

  1363.       </li>
    1364. 

  1364.       <li>
    1365. 

  1365.         <strong>PNAS 2024</strong> (Seo et al.) — 肠道Akkermansia与AD · <a href="https://doi.org/10.1073/pnas.2315278121" target="_blank" rel="noopener">doi:10.1073/pnas.2315278121</a>
    1366. 

  1366.         <span class="translation">《美国国家科学院院刊》2024年，Akkermansia muciniphila通过调节肠道屏障改善AD病理</span>
    1367. 

  1367.       </li>
    1368. 

  1368.       <li>
    1369. 

  1369.         <strong>Alzheimer's & Dementia 2025</strong> (Livingston et al.) — Lancet 2024更新 · <a href="https://doi.org/10.1002/alz.14363" target="_blank" rel="noopener">doi:10.1002/alz.14363</a>
    1370. 

  1370.         <span class="translation">《柳叶刀》2024年痴呆预防、干预和护理委员会更新报告</span>
    1371. 

  1371.       </li>
    1372. 

  1372.     </ol>
    1373. 

  1373.     
    1374. 

  1374.     <div class="highlight-box green" style="margin-top:2rem;">
    1375. 

  1375.       <p><strong>核心结论：</strong>AD是Aβ/Tau沉积、慢性神经炎症、血管因素、遗传等多因素共同驱动的复杂疾病。近年研究揭示肠道菌群失调通过肠脑轴驱动小胶质细胞过度激活，可能是延缓认知衰退的新干预靶点。早期识别和积极的生活方式干预是预防AD的关键。</p>
    1376. 

  1376.     </div>
    1377. 

  1377.   </div>
    1378. 

  1378. </section>
    1379. 

  1379. 

  1380. <!-- ===== CTA ===== -->
    1381. 

  1381. <section class="cta-section" style="background:linear-gradient(135deg,#1a0a2e 0%,#3d1e5c 100%);">
    1382. 

  1382.   <div class="container">
    1383. 

  1383.     <h2>熄灭大脑里的神经炎症之火，从修复肠道开始</h2>
    1384. 

  1384.     <p>阿尔茨海默病不是衰老的必然结局——而是慢性神经炎症在大脑里静默燃烧了20年。<br>而神经炎症的最大来源是失衡的肠道菌群。评估炎症负荷 → 修复肠漏（肠脑轴） → 抗炎干预。在神经元不可逆损伤之前，你有足够的时间改写命运。</p>
    1385. 

  1385.     <div class="cta-buttons">
    1386. 

  1386.       <a href="../index.html" class="btn btn-primary">🏠 返回首页</a>
    1387. 

  1387.       <a href="https://www.etotem.com.cn" class="btn btn-outline" target="_blank">了解主动健康服务</a>
    1388. 

  1388.     </div>
    1389. 

  1389.   </div>
    1390. 

  1390. </section>
    1391. 

  1391. 

  1392. <!-- Footer (shared) -->
    1393. 

  1393. <div id="footer-placeholder"></div>
    1394. 

  1394. <script src="js/footer.js"></script>
    1395. 

  1395. 

  1396. </body>
    1397. 

  1397. </html>
    1398.